Dengue fever (dengue fever, also known as dengue fever and tengu fever in Singapore and Malaysia) is a mosquito-borne tropical disease caused by the dengue virus [1]. Patients will develop symptoms approximately 3 to 14 days after infection [2], with symptoms including fever, headache, muscle and joint pain, and a typical morbilliform rash [1][2]. Merck & Co., Inc. (Merck & Co., Inc. outside the United States and Canada) is a health care leader working to improve well-being around the world. Merck & Co., Inc. Kenilworth, New Jersey, USA. From developing new therapies to treat and prevent disease to meeting people's needs, we work to improve the health and well-being of people around the world. This manual was first published in 1899 as a community service. This treasure. Dengue vaccine (merck sharp & dohme) is a live attenuated vaccine developed by Merck. The current highest development stage of this drug is clinical phase III.
UPMC Shift Select Transforming Healthcare Scheduling
Dengue hemorrhagic fever is a more severe form of dengue fever. It mainly affects children under 10 years old in areas where dengue fever is common. If you have dengue hemorrhagic fever, in addition to dengue fever symptoms, you may also have: Bleeding from the nose, mouth, rectum, and puncture wounds Stomach pain Vomiting blood Bloody stools or hematuria Bleeding under the skin that causes purple spots on the skin Extremely low blood pressure (shock) If you have dengue hemorrhagic fever symptoms, go to the hospital right away.
